Monthly Archives: January 2018
What is Happening with the Provisional Approval Pathway?
We’ve come a long way When the independent review of medicines and medical devices regulation was announced in October 2014, the pharmaceutical sector immediately saw the opportunity for an expediated approval pathway for certain prescription medicines. A provisional approval pathway would allow … Continue reading
Posted in Life Sciences Industry, Regulatory Services, TGA
Tagged Community Affairs, Regulatory Pathway, TGA
Comments Off on What is Happening with the Provisional Approval Pathway?
